Figure 5.
Topically administered TSP-derived peptides attenuate ovalbumin-specific antibody response in immunized TSP1−/− mice. (a) Timeline of ovalbumin (OVA) immunization and subsequent treatment of TSP1−/− mice with TSP1-derived peptide (N1K) or control peptide (NGG). (b) Serum anti-OVA IgG levels as determined by ELISA; Mean Ab level +/− SEM. Data are representative of two independent experiments; * p < 0.05.